Tytuł pozycji:

Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)

Tytuł:: Meropenem Versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream Infections Caused by AmpC β-Lactamase–Producing Enterobacter spp, Citrobacter freundii, Morganella morganii, Providencia spp, or Serratia marcescens: A Pilot Multicenter Randomized Controlled Trial (MERINO-2)
Autorzy:: Stewart, Adam G (AUTHOR)
Paterson, David L (AUTHOR)
Young, Barnaby (AUTHOR)
Lye, David C (AUTHOR)
Davis, Joshua S (AUTHOR)
Schneider, Kellie (AUTHOR)
Yilmaz, Mesut (AUTHOR)
Dinleyici, Rumeysa (AUTHOR)
Runnegar, Naomi (AUTHOR)
Henderson, Andrew (AUTHOR)
Archuleta, Sophia (AUTHOR)
Kalimuddin, Shirin (AUTHOR)
Forde, Brian M (AUTHOR)
Chatfield, Mark D (AUTHOR)
Bauer, Michelle J (AUTHOR)
Lipman, Jeffrey (AUTHOR)
Harris-Brown, Tiffany (AUTHOR)
Harris, Patrick N A (AUTHOR)
(ASID-CRN), MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (AUTHOR)
Źródło:: Open Forum Infectious Diseases. Aug2021, Vol. 8 Issue 8, p1-12. 12p.
: Czasopismo naukowe

Pełny tekst

Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Informacja